Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tevogen Bio Holdings (TVGN) just unveiled an update.
Tevogen Bio Holdings Inc. has repurchased all outstanding shares of its Series B Preferred Stock from SSVK Associates, LLC, reassuming $3.6 million in liabilities without affecting its last reported balance sheet. Meanwhile, the company faces challenges with Nasdaq’s minimum bid price requirement, having received notice that its stock price fell short of the $1 threshold over 35 consecutive days. Tevogen has 180 days to rectify the situation before potentially facing delisting, though it may seek an additional grace period and is exploring options to meet Nasdaq’s standards.
See more insights into TVGN stock on TipRanks’ Stock Analysis page.
